Diabetic Assays Market Would Grow upto USD 4.6 Billion by 2030

PRESS RELEASE
Published August 21, 2023

Global Diabetic Assays Market research report offers CAGR value fluctuations during the forecast period of 2023-2030 for the market. It is a fully informative and proficient report that focuses on primary and secondary market drivers, market share, leading segments and geographical analysis. A proficient team works meticulously with their potential capabilities to generate this finest market research report. The winning Global Diabetic Assays Market report is a specific study of the HELATH industry which explains what the market definition, classifications, applications, engagements, and global industry trends are. This report helps to stay on the right path by making to focus on the data and realities of the industry.

Diabetes is one of the most severe endocrine diseases. Around 425 million people globally suffer from this disease. Rising incidence of diabetes and awareness of it increases the market growth.  For instance, World Health Organization (WHO) expected around 125 million people aged 80 years or older, estimated to be almost 2 billion by the year 2050 in 2018. The demand for diabetes assays is being boosted by the need for easier, economic, and more efficient management of the global diabetes epidemic and increasing development of non-invasive techniques

Data Bridge Market Research analyses a growth rate in the diabetic assays market in the forecast period 2023-2030. The expected CAGR of diabetic assays market is tend to be around 4.50% in the mentioned forecast period. The market is valued at USD 3.23 billion in 2022, and it would grow upto USD 4.6 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-diabetic-assays-market&Shri

Market Overview:

Diabetics assays such as auto-antibody assay, Electro-Chemiluminescence assays, enzyme inhibition assay, ELISA assay and others are widely used for the diabetes diagnosis. Diabetics cause severe damage to the heart, eyes, blood vessels, kidney and nerves. Increased risk of cardiac disorders related with diabetes requires successful testing and diagnosis options.

Opportunities

  • Wide Adoption of Blood Glucose Meters

The increasing adoption of blood glucose meters is slowly increasing because of advantages such as portability and accuracy. Several market players are also primarily focusing on developing these devices and are launching small blood glucose meters. Some of the smallest blood glucose meters with advanced technology are widely available in the U.K. These are Abbott Diabetes Care Freestyle Lite, Lifescan’s One Touch UltraEasy, Bayer’s CONTOUR NEXT USB, Accu-Chek Aviva Nano, TRUEone blood glucose meter and Accu-Chek Mobile. Introducing these small, discreet, and easy-to-use blood glucose meters is anticipated to increase segment growth in the upcoming years. This as a result, increases the demand for the market.

  • Rising Cases of Diabetes and Obesity

Rise in prevalence of diabetes because of aging, obesity, and unhealthy lifestyle is one of the primary factors leading to the growth of the market. Obesity is a major factor leading to diabetes. According to World Health Organization,  in 2016, more than 1.9 billion adults were overweight, about 650 million people were obese. Several risk factors, such as obesity and overweight, are causing an increase in the prevalence of diabetes. Thus, risk factors such as overweight, obesity, smoking, and high cholesterol levels are anticipated to boost the prevalence of diabetes, thus fuelling the need for diabetes devices.

 Restraints/Challenges

  • High Cost of Treatment

The increasing expenditure associated with the glucose meters and other instruments and the cost required to conduct the assays impede the market growth. Numerous drugs and surgeries cost high, and people in highly developing and underdeveloped countries cause the under treatment of numerous patients. This impedes the market growth.

This diabetic assays market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the diabetic assays market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In 2019, Abbott (U.S.) launched its first rapid point-of-care HbA1c test to diagnose diabetes “Afinion HbA1c Dx assay” for use on Afinion AS100 Analyzer and Afinion 2 Analyzer. The Afinion HbA1c Dx assay is the first and rapid point-of-care method approved by the U.S. FDA to support various healthcare professionals in the diagnosis and treatment of diabetes. This launch will enhance the product portfolio and user base of the company.
  • In 2019, Beckman Coulter, Inc, hemoglobin A1c (HbA1c) Advanced assay received CE Mark Certification and the U.S. FDA 501(k) Clearance. The company will provide initial diagnosis of diabetes and will also aid the clinically operative outcomes.

Fundamental Aim of this Market Report

  • Factors influencing This Market Size and growth rate.
  • Major alterations to this market in the near future.
  • Notable Market rivals around the world.
  • Future Scope and Product Outlook
  • Future-promising emerging markets.
  • The Market Presents Difficult Challenges and Threats.

Key players operating in the diabetic assays market include:

  • Abbvie, Inc (U.S.)
  • Novartis AG (Switzerland)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Pfizer Inc (U.S.)
  • Merck & Co., Inc. (U.S.)
  • Abbott (U.S.)
  • Siemens Healthcare GmbH (Germany)
  • Hologic, Inc. (U.S.)
  • Dynatronics Corporation (U.S.)
  • Biomerieux (France)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • BioMarin (U.S.)
  • Quotient Suisse SA (Switzerland)
  • BAG Health Care GmbH (Germany)
  • DiaSorin S.p.A (Italy)
  • DRG INSTRUMENTS GMBH (Germany)
  • PTS Diagnostics (U.S.)
  • Ortho Clinical Diagnostics (U.S.)
  • Diazyme Laboratories, Inc (U.S.)
  • ETHOS BIOSCIENCES (U.S.)
  • Abnova Corporation (Taiwan)
  • Monobind Inc. (U.S.)

To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@  https://www.databridgemarketresearch.com/reports/global-diabetic-assays-market?Shri

Diabetic Assays Market Scope

Type  

  • Assays
  • Devices
  • Consumables

Disease Type

  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes

Deployment

  • Automated
  • Manual

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Key highlights of this Market report:

  • Growth rate
  • Remuneration prediction
  • Consumption graph
  • Market concentration ratio
  • Secondary industry competitors
  • Competitive structure
  • Major restraints
  • Market drivers
  • Regional bifurcation
  • Competitive hierarchy
  • Current market tendencies
  • Market concentration analysis

What benefits does the DBMR study is going to provide?

  • Latest industry influencing trends and development scenario
  • Open up New Markets
  • To Seize powerful market opportunities
  • Key decision in planning and to further expand market share
  • Identify Key Business Segments, Market proposition & Gap Analysis
  • Assisting in allocating marketing investments

Table of Contents:

  1. Introduction
  2. Market Segmentation
  3. Executive Summary
  4. Premium Insights
  5. Market Regulations
  6. Market Overview

Continued…

Browse Detailed Summary of Research Report with TOC:  https://www.databridgemarketresearch.com/toc/?dbmr=global-diabetic-assays-market&Shri

Key Benefits of the Report:

  • This study presents the analytical depiction of this industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of this market share.
  • The current market is quantitatively analyzed to highlight the market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed this industry analysis based on competitive intensity and how the competition will take shape in the coming years.

Top DBMR Healthcare Reports:        

https://www.databridgemarketresearch.com/reports/global-cardasil-treatment-market?Shri

https://www.databridgemarketresearch.com/reports/global-aestheticcosmetic-lasers-market?Shri

https://www.databridgemarketresearch.com/reports/global-pharmaceutical-laboratory-information-management-systems-market?Shri

https://www.databridgemarketresearch.com/reports/global-protein-crystallization-crystallography-market?Shri

https://www.databridgemarketresearch.com/reports/india-analytical-chromatography-in-pharma-quality-control-market?Shri

https://www.databridgemarketresearch.com/reports/global-yeast-infection-market?Shri

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475

Email:- corporatesales@databridgemarketresearch.com

CDN Newswire